Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach

  • 141 Accesses

  • 11 Citations


The incomplete intestinal metaplasia (IM) that is reported to be a risk factor for gastric carcinogenesis in man usually features sulfomucin production and thus is considered of colonic type. To cast light on the underlying mechanisms, we here examined the proportions of colonic and small intestinal phenotypes in IM by immunohistochemistry and real-time reverse transcription–polymerase chain reaction at the single isolated gland level. Carbonic anhydrase 1 (CA1) is a specific marker of colonic epithelial cells, whereas sucrase is specific to absorptive cells of the small intestine. Totals of 139 (23.5%) and 452 (76.5%) IM glands were judged to be CA1 positive and CA1 negative, respectively, in resected pyloric mucosa from cancer patients. The average score for MUC5AC in CA1-positive IMs was significantly lower than in CA1-negative counterpart tissue (P<0.0001), whereas the opposite was the case for sucrase (P<0.0001). High iron diamine–Alcian blue staining revealed CA1 expression to coincide with type I complete IM. The expression of CA1 mRNA strongly correlated with that of sucrase–isomaltase, and inversely with that of MUC5AC in isolated IM glands. In conclusion, CA1 could be colocalized with small intestinal proteins such as sucrase, but only rarely with the gastric mucin, MUC5AC. Its expression warrants further study, with the focus on stimulation and/or suppression mechanisms by gastric and intestinal transcription factors.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7


  1. 1.

    Correa P (1988) A human model of gastric carcinogenesis. Cancer Res 48:3554–3560

  2. 2.

    Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735–6740

  3. 3.

    Correa P (1995) Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19(Suppl 1):S37–S43

  4. 4.

    Drummond F, Sowden J, Morrison K, Edwards YH (1996) The caudal-type homeobox protein Cdx-2 binds to the colon promoter of the carbonic anhydrase 1 gene. Eur J Biochem 236:670–681

  5. 5.

    Drummond FJ, Sowden J, Morrison K, Edwards YH (1998) Colon carbonic anhydrase 1: transactivation of gene expression by the homeodomain protein Cdx2. FEBS Lett 423:218–222

  6. 6.

    Ectors N, Dixon MF (1986) The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 10:1271–1277

  7. 7.

    Eda A, Osawa H, Yanaka I, Satoh K, Mutoh H, Kihira K, Sugano K (2002) Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 37:94–100

  8. 8.

    Egashira Y, Shimoda T, Ikegami M (1999) Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 49:55–61

  9. 9.

    Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T (2000) Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 191:257–263

  10. 10.

    Filipe MI, Potet F, Bogomoletz WV, Dawson PA, Fabiani B, Chauveinc P, Fenzy A, Gazzard B, Goldfain D, Zeegen R (1985) Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 26:1319–1326

  11. 11.

    Hattori T (1986) Development of adenocarcinomas in the stomach. Cancer 57:1528–1534

  12. 12.

    Huang CB, Xu J, Huang JF, Meng XY (1986) Sulphomucin colonic type intestinal metaplasia and carcinoma in the stomach. A histochemical study of 115 cases obtained by biopsy. Cancer 57:1370–1375

  13. 13.

    Inada K, Nakanishi H, Fujimitsu Y, Shimizu N, Ichinose M, Miki K, Nakamura S, Tatematsu M (1997) Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol Int 47:831–841

  14. 14.

    Jass JR, Filipe MI (1979) A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 3:191–199

  15. 15.

    Kawachi H, Takizawa T, Eishi Y, Shimizu S, Kumagai J, Funata N, Koike M (2003) Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol 199:436–446

  16. 16.

    Kawachi T, Kogure K, Tanaka N, Tokunaga A, Sugimura T (1974) Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharidases with “Tes-Tape”. J Natl Cancer Inst 53:19–30

  17. 17.

    Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120:103–111

  18. 18.

    Matsukuma A, Mori M, Enjoji M (1990) Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 66:689–694

  19. 19.

    Mizoshita T, Inada K, Tsukamoto T, Kodera Y, Yamamura Y, Hirai T, Kato T, Joh T, Itoh M, Tatematsu M (2001) Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa—with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 4:185–191

  20. 20.

    Mizoshita T, Joh T, Oshima T, Yamada T, Ohara H, Nomura T, Okada N, Itoh M (2002) Differential expression of decay-accelerating factor isoforms in the digestive tract of guinea pig. Life Sci 70:867–876

  21. 21.

    Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M (2003) Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 129:727–734

  22. 22.

    Mizoshita T, Inada K, Tsukamoto T, Nozaki K, Joh T, Itoh M, Yamamura Y, Ushijima T, Nakamura S, Tatematsu M (2004a) Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol 130:29–36

  23. 23.

    Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M (2004b) Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 54:392–400

  24. 24.

    Morson BC (1955) Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 9:377–385

  25. 25.

    Mutoh H, Hakamata Y, Sato K, Eda A, Yanaka I, Honda S, Osawa H, Kaneko Y, Sugano K (2002) Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 294:470–479

  26. 26.

    Niwa T, Ikehara Y, Nakanishi H, Tanaka H, Inada K, Tsukamoto T, Ichinose M, Tatematsu M (2005) Mixed gastric- and intestinal-type Metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem 53:75–85

  27. 27.

    Nozaki K, Shimizu N, Tsukamoto T, Inada K, Cao X, Ikehara Y, Kaminishi M, Sugiyama A, Tatematsu M (2002b) Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian Gerbils on eradication. Jpn J Cancer Res 93:374–381

  28. 28.

    Otsuka T, Tsukamoto T, Mizoshita T, Inada K, Takenaka Y, Kato S, Yamamura Y, Miki K, Tatematsu M (2005) Coexistence of gastric and intestinal type endocrine cells in gastric-and-intestinal mixed intestinal metaplasia of the human stomach. Pathol Int (in press)

  29. 29.

    Parkkila S, Parkkila AK, Juvonen T, Rajaniemi H (1994) Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract. Gut 35:646–650

  30. 30.

    Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M (1999) Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59:1003–1007

  31. 31.

    Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G (2001) Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 51:165–171

  32. 32.

    Segura DI, Montero C (1983) Histochemical characterization of different types of intestinal metaplasia in gastric mucosa. Cancer 52:498–503

  33. 33.

    Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, Sackett SD, Kaestner KH (2002) Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122:689–696

  34. 34.

    Silva E, Teixeira A, David L, Carneiro F, Reis CA, Sobrinho-Simoes J, Serpa J, Veerman E, Bolscher J, Sobrinho-Simoes M (2002) Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 440:311–317

  35. 35.

    Sowden J, Leigh S, Talbot I, Delhanty J, Edwards Y (1993) Expression from the proximal promoter of the carbonic anhydrase 1 gene as a marker for differentiation in colon epithelia. Differentiation 53:67–74

  36. 36.

    Stemmermann GN, Hayashi T (1968) Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst 41:627–634

  37. 37.

    Suh E, Chen L, Taylor J, Traber PG (1994) A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 14:7340–7351

  38. 38.

    Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, Satoh K, Sekiyama S, Suzuki A, Eda Y, Satodate R (1995) Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 55:1933–1936

  39. 39.

    Tatematsu M, Katsuyama T, Fukushima S, Takahashi M, Shirai T, Ito N, Nasu T (1980) Mucin histochemistry by paradoxical concanavalin A staining in experimental gastric cancers induced in Wistar rats by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline 1-oxide. J Natl Cancer Inst 64:835–843

  40. 40.

    Tatematsu M, Furihata C, Katsuyama T, Hasegawa R, Nakanowatari J, Saito D, Takahashi M, Matsushima T, Ito N (1983) Independent induction of intestinal metaplasia and gastric cancer in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res 43:1335–1341

  41. 41.

    Tatematsu M, Katsuyama T, Furihata C, Tsuda H, Ito N (1984) Stable intestinal phenotypic expression of gastric and small intestinal tumor cells induced by N-methyl-N′-nitro-N-nitrosoguanidine or methylnitrosourea in rats. Gann 75:957–965

  42. 42.

    Tatematsu M, Furihata C, Katsuyama T, Miki K, Honda H, Konishi Y, Ito N (1986) Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 46:4866–4872

  43. 43.

    Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N (1990a) Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 40:494–504

  44. 44.

    Tatematsu M, Fukami H, Yamamoto M, Nakanishi H, Masui T, Kusakabe N, Sakakura T (1994) Clonal analysis of glandular stomach carcinogenesis in C3H/HeN⇔BALB/c chimeric mice treated with N-methyl-N-nitrosourea. Cancer Lett 83:37–42

  45. 45.

    Tatematsu M, Tsukamoto T, Inada K (2003) Stem cells and gastric cancer—role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94:135–141

  46. 46.

    Teglbjaerg PS, Nielsen HO (1978) “Small intestinal type” and “colonic type” intestinal metaplasia of the human stomach, and their relationship to the histogenetic types of gastric adenocarcinoma. Acta Pathol Microbiol Scand, A 86A:351–355

  47. 47.

    Tsukamoto T, Yoo J, Hwang SI, Guzman RC, Hirokawa Y, Chou YC, Olatunde S, Huang T, Bera TK, Yang J, Nandi S (2000) Expression of MAT1/PEA-15 mRNA isoforms during physiological and neoplastic changes in the mouse mammary gland. Cancer Lett 149:105–113

  48. 48.

    Tsukamoto T, Fukami H, Yamanaka S, Yamaguchi A, Nakanishi H, Sakai H, Aoki I, Tatematsu M (2001) Hexosaminidase-altered aberrant crypts, carrying decreased hexosaminidase alpha and beta subunit mRNAs, in colon of 1,2-dimethylhydrazine-treated rats. Jpn J Cancer Res 92:109–118

  49. 49.

    Tsukamoto T, Inada K, Tanaka H, Mizoshita T, Mihara M, Ushijima T, Yamamura Y, Nakamura S, Tatematsu M (2004) Down regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 130:135–145

  50. 50.

    Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M (2005) Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology (in press)

  51. 51.

    Yoshikawa A, Inada Ki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M (1998) Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1:134–141

  52. 52.

    You WC, Blot WJ, Li JY, Chang YS, Jin ML, Kneller R, Zhang L, Han ZX, Zeng XR, Liu WD et al (1993) Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 53:1317–1321

  53. 53.

    Yuasa H, Hirano K, Kodama H, Nakanishi H, Imai T, Tsuda H, Imaida K, Tatematsu M (1994) Immunohistochemical demonstration of intestinal-type alkaline phosphatase in stomach tumors induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. Jpn J Cancer Res 85:897–903

  54. 54.

    Yuasa H, Inada K, Watanabe H, Tatematsu M (2002) A phenotypic shift from gastric-intestinal to solely intestinal cell types in intestinal metaplasia in rat stomach following treatment with X-rays. J Toxicol Pathol 15:85–93

  55. 55.

    Yuasa Y (2003) Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3:592–600

Download references


This study was supported in part by a Grant-in-Aid for the Third-term Comprehensive 10-year Strategy for Cancer Control and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan, and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors thank Dr. Malcolm A. Moore for revision of the scientific English language and Ms. Hisayo Ban for expert technical assistance. The anti-sucrase antibody was a generous gift from Dr. Kazuyuki Hirano, Department of Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan.

Author information

Correspondence to Tetsuya Tsukamoto.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tanaka, H., Tsukamoto, T., Mizoshita, T. et al. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach. Virchows Arch 447, 806–815 (2005). https://doi.org/10.1007/s00428-005-0040-1

Download citation


  • Intestinal metaplasia
  • Carbonic anhydrase 1
  • Sucrase
  • Stomach
  • Gland isolation